Elanco Animal Health Incorporated Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal
Elanco Animal Health Incorporated (ELAN) reported Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal of $0 for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-07.
Discontinued › Income Statement › Other Income
us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal · last filed 2023-08-07
- Elanco Animal Health Incorporated disposal group, not discontinued operation, gain (loss) on disposal for the quarter ending 2023-06-30 was $0.00.
- Elanco Animal Health Incorporated disposal group, not discontinued operation, gain (loss) on disposal for the quarter ending 2022-12-31 was -$2.00M.
- Elanco Animal Health Incorporated disposal group, not discontinued operation, gain (loss) on disposal for the quarter ending 2022-09-30 was $0.00.
- Elanco Animal Health Incorporated disposal group, not discontinued operation, gain (loss) on disposal for the quarter ending 2022-06-30 was -$2.00M.
- Elanco Animal Health Incorporated disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2022 was -$4.00M.
- Elanco Animal Health Incorporated disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2021 was -$41.00M.
- Elanco Animal Health Incorporated disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2020 was -$15.00M.
| Period end | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 3 month | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 3 month as first filed | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 6 month | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 6 month as first filed | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 9 month | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 9 month as first filed | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 12 month |
|---|---|---|---|---|---|---|---|
| 2023-06-30 | $0.00 10-Q · filed 2023-08-07 | $0.00 10-Q · filed 2023-08-07 | |||||
| 2022-12-31 | -$2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$2.00M derived: sum of 2 quarters · filed 2023-03-01 | -$4.00M derived: sum of 3 quarters · filed 2023-08-07 | -$4.00M 10-K · filed 2023-03-01 | |||
| 2022-09-30 | $0.00 10-Q · filed 2022-11-08 | -$2.00M derived: sum of 2 quarters · filed 2023-08-07 | -$2.00M 10-Q · filed 2022-11-08 | -$4.00M derived: sum of 4 quarters · filed 2023-08-07 | |||
| 2022-06-30 | -$2.00M 10-Q · filed 2023-08-07 | -$2.00M 10-Q · filed 2023-08-07 | -$4.00M derived: sum of 3 quarters · filed 2023-08-07 | -$40.00M derived: sum of 4 quarters · filed 2023-08-07 | |||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-09 | -$2.00M derived: sum of 2 quarters · filed 2023-03-01 | -$38.00M derived: sum of 3 quarters · filed 2023-03-01 | -$43.00M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2021-12-31 | -$2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$38.00M derived: sum of 2 quarters · filed 2023-03-01 | -$43.00M derived: sum of 3 quarters · filed 2023-03-01 | -$41.00M 10-K · filed 2023-03-01 | |||
| 2021-09-30 | -$36.00M 10-Q · filed 2022-11-08 | -$27.00M 10-Q · filed 2021-11-05 | -$41.00M derived: sum of 2 quarters · filed 2022-11-08 | -$39.00M 10-Q · filed 2022-11-08 | -$13.00M 10-Q · filed 2021-11-05 | -$52.00M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-06-30 | -$5.00M 10-Q · filed 2022-08-08 | $3.00M 10-Q · filed 2021-08-09 | -$3.00M 10-Q · filed 2022-08-08 | $14.00M 10-Q · filed 2021-08-09 | -$16.00M derived: sum of 3 quarters · filed 2023-03-01 | -$16.00M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-03-31 | $1.00M 10-Q · filed 2022-05-09 | $10.00M 10-Q · filed 2021-05-07 | -$11.00M derived: sum of 2 quarters · filed 2023-03-01 | -$11.00M derived: sum of 3 quarters · filed 2023-03-01 | -$14.00M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2020-12-31 | -$12.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$12.00M derived: sum of 2 quarters · filed 2023-03-01 | -$15.00M derived: sum of 3 quarters · filed 2023-03-01 | -$15.00M 10-K · filed 2023-03-01 | |||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-05 | -$3.00M derived: sum of 2 quarters · filed 2021-11-05 | -$3.00M 10-Q · filed 2021-11-05 | -$3.10M 10-Q · filed 2020-11-06 | |||
| 2020-06-30 | -$3.00M 10-Q · filed 2021-08-09 | -$3.10M 10-Q · filed 2020-07-30 | -$3.00M 10-Q · filed 2021-08-09 | -$3.10M 10-Q · filed 2020-07-30 | |||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-07 | ||||||
| 2019-09-30 | $0.00 10-Q · filed 2020-11-06 | $0.00 derived: sum of 2 quarters · filed 2020-11-06 | |||||
| 2019-06-30 | $0.00 10-Q · filed 2020-07-30 | $0.00 10-Q · filed 2020-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |